N. Fleshner et al., Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder, CANCER, 86(11), 1999, pp. 2337-2345
BACKGROUND. The aim of this study was to assess the influence of tobacco ex
posure, at the time of diagnosis, on the disease-related outcomes of patien
ts with tobacco-associated superficial transitional cell carcinoma (TCC) of
the bladder.
METHODS. A retrospective cohort study was performed using the MSKCC Registr
y to identify all institutional cases of "noninvasive" TCC (n = 1632) betwe
en 1985 and 1995. After employing exclusion criteria, 286 cases of incident
tobacco-associated superficial TCC were divided into 3 strata of tobacco e
xposure (127 ex-smokers, 51 quitters, and 108 continued smokers) by chart r
eview and post hoc questionnaires (n = 82). Measured outcomes included recu
rrence free survival and survival free of adverse events (defined a priori
as disease progression or other urinary tract TCC).
RESULTS. There were no significant differences among ex-smokers, quitters,
and continued smokers in terms of stage, grade, tumor size, multifocality,
up-front bacillus Calmette-Guerin therapy, or median follow-up. Ex-smokers
presented at a later age than individuals who continued to smoke. Post hoc
questionnaires and chart reviews were compared in terms of smoking status a
t time of diagnosis, and reliability was excellent (kappa = 0.89). Multivar
iate analyses revealed diminished recurrence free survival among continued
smokers versus quitters or ex-smokers. Univariate analyses revealed diminis
hed adverse event free survival among continued smokers versus quitters or
ex-smokers. Multivariate models assessing adverse event free survival revea
led a similar trend (P = 0.06).
CONCLUSIONS. Continued smokers experience worse disease-associated outcomes
than patients who quit smoking. Smoking cessation should thus be employed
as a tertiary prevention strategy for patients with superficial TCC. [See e
ditorial on pages 2192-4, this issue]. (C) 1999 American Cancer Society.